Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suboxone Induction in Heroin Users
NCT00604188Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Suboxone in opioid use disorder (OUD) (2 arms), sponsored by Merck & Co. Primary endpoint: Responders at Day 3. Started Feb 2008; status: completed.
02
Drugs
Suboxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00604188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604188.